Anti-PI 3 Kinase p85 beta antibody [T15] (ab28356)
- Datasheet
- References (9)
- Protocols
Overview
-
Product name
Anti-PI 3 Kinase p85 beta antibody [T15]
See all PI 3 Kinase p85 beta primary antibodies -
Description
Mouse monoclonal [T15] to PI 3 Kinase p85 beta -
Host species
Mouse -
Specificity
T15 recognises the p85 beta subunit of bovine PI 3 kinase. It does not cross react with the p85 alpha subunit. -
Tested applications
Suitable for: IHC-Fr, IP, WBmore details -
Species reactivity
Reacts with: Human, Monkey
Predicted to work with: Mouse, Rat
-
Immunogen
Balculovirus expressed (Recombinant) bovine P85 beta subunit of PI 3 kinase.
-
Positive control
- Lysates of SF9 cells infected with baculovirus expressing p85 beta.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. -
Storage buffer
Preservative: 0.09% Sodium azide -
Concentration information loading... -
Purity
Protein G purified -
Purification notes
This antibody is purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant. -
Clonality
Monoclonal -
Clone number
T15 -
Myeloma
NS1 -
Isotype
IgG1 -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
Applications
Our Abpromise guarantee covers the use of ab28356 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| IHC-Fr | Use at an assay dependent concentration. | |
| IP | 1/25. Use 25ul. | |
| WB | 1/1000 - 1/5000. Predicted molecular weight: 82 kDa. |
Target
-
Function
Regulatory subunit of phosphoinositide-3-kinase (PI3K), a kinase that phosphorylates PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Binds to activated (phosphorylated) protein-tyrosine kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Indirectly regulates autophagy (PubMed:23604317). Promotes nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement. -
Involvement in disease
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 -
Sequence similarities
Belongs to the PI3K p85 subunit family.
Contains 1 Rho-GAP domain.
Contains 2 SH2 domains.
Contains 1 SH3 domain. -
Domain
The SH2 2 domain is required for interaction with FBXL2 and PTPN13. -
Post-translational
modificationsPhosphorylated in response to signaling from activated receptor-type protein kinases (PubMed:19690332, PubMed:20068231). Dephosphorylated by PTPRJ (PubMed:18348712). Dephosphorylated at Tyr-655 by PTPN13. Phosphorylation of Tyr-655 impairs while its dephosphorylation promotes interaction with FBXL2 and SCF(FBXL2)-mediated polyubiquitination (PubMed:23604317).
Ubiquitinated. Polyubiquitination by the SCF(FBXL2) complex probably promotes proteasomal degradation of PIK3R2. - Information by UniProt
-
Database links
- Entrez Gene: 5296 Human
- Entrez Gene: 18709 Mouse
- Entrez Gene: 29741 Rat
- Omim: 603157 Human
- SwissProt: O00459 Human
- SwissProt: O08908 Mouse
- SwissProt: Q63788 Rat
- Unigene: 371344 Human
see all -
Alternative names
- p85 antibody
- p85 beta antibody
- P85B antibody
see all
Images
-
![Western blot - Anti-PI 3 Kinase p85 beta antibody [T15] (ab28356)](https://www.abcam.com/ps/products/28/ab28356/Images/ab28356-39274-anti-pi-3-kinase-p85-beta-antibody-t15-western-blot.jpg)
Western blot - Anti-PI 3 Kinase p85 beta antibody [T15] (ab28356)Western Blotting of HEK293 and HepG2 cell lysates with Mouse anti Bovine PI-3 kinase p85 subunit beta (ab28356), recombinant p85ß is included as a positive control.
Datasheets and documents
References
This product has been referenced in:
- Pedini F et al. Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanoma. Mol Oncol 13:1836-1854 (2019). Read more (PubMed: 31115969) »
- Dai K et al. Kbtbd2 inhibits the cytotoxic activity of immortalized NK cells through down-regulating mTOR signaling in a mouse hepatocellular carcinoma model. Eur J Immunol 48:683-695 (2018). Read more (PubMed: 29331106) »
